Do we know how to achieve optimal response to pegylated interferon alpha and rihavirin?

被引:1
作者
Heathcote, J [1 ]
机构
[1] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.1016/S0168-8278(03)00197-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:136 / 138
页数:3
相关论文
共 7 条
[1]   Monitoring of viral levels during therapy of hepatitis C [J].
Davis, GL .
HEPATOLOGY, 2002, 36 (05) :S145-S151
[2]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[3]   Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis [J].
Heathcote, EJ ;
Shiffman, ML ;
Cooksley, WGE ;
Dusheiko, GM ;
Lee, SS ;
Balart, L ;
Reindollar, R ;
Reddy, RK ;
Wright, TL ;
Lin, A ;
Hoffman, J ;
De Pamphilis, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23) :1673-1680
[4]   Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C [J].
Jen, JF ;
Glue, P ;
Ezzet, F ;
Chung, C ;
Gupta, SK ;
Jacobs, S ;
Hajian, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) :407-421
[5]  
Lamb MW, 2002, ANN PHARMACOTHER, V36, P933
[6]   Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].
Manns, MP ;
McHutchison, JG ;
Gordon, SC ;
Rustgi, VK ;
Shiffman, M ;
Reindollar, R ;
Goodman, ZD ;
Koury, K ;
Ling, MH ;
Albrecht, JK .
LANCET, 2001, 358 (9286) :958-965
[7]   A randomized, controlled trial of maintenance inteferon therapy for patients with chronic hepatitis C virus and persistent viremia [J].
Shiffman, ML ;
Hofmann, CM ;
Contos, MJ ;
Luketic, VA ;
Sanyal, AJ ;
Sterling, RK ;
Ferreira-Gonzalez, A ;
Mills, AS ;
Garret, C .
GASTROENTEROLOGY, 1999, 117 (05) :1164-1172